⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
AKBA News
Akebia Therapeutics, Inc.
Breath Analyzers Market worth $5.63 billion by 2031 | MarketsandMarkets™
prnewswire.com
LOCO
ABT
AKBA
BAC
CMII
Akebia Therapeutics to Present at the Leerink Partners 2026 Global Healthcare Conference
globenewswire.com
AKBA
Akebia Therapeutics to Present at the Leerink Partners 2026 Global Healthcare Conference
globenewswire.com
AKBA
Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
AKBA
Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
AKBA
Form 8-K
sec.gov
AKBA
Akebia Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Commercial and Pipeline Highlights
globenewswire.com
AKBA
Akebia Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results and Discuss Recent Business Highlights
globenewswire.com
AKBA
Akebia Therapeutics to Present at the Guggenheim Emerging Outlook: Biotech Summit 2026
globenewswire.com
AKBA
Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
AKBA